Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis

Abstract Background Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is unclear. The aim of this study is to...

Full description

Bibliographic Details
Published in:	Arthritis Research & Therapy
Main Authors:	Jayne Moxey, Molla Huq, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jenny Walker, Gemma Strickland, Michelle Wilson, Laura Ross, Gabor Major, Janet Roddy, Wendy Stevens, Mandana Nikpour
Format:	Article
Language:	English
Published:	BMC 2019-02-01
Subjects:	Anti-neutrophil cytoplasmic antibodies (ANCA) Systemic sclerosis (SSc) ANCA-associated vasculitis Myeloperoxidase (MPO) Proteinase-3 (PR3)
Online Access:	http://link.springer.com/article/10.1186/s13075-019-1839-5

Similar Items

Differences in Radiological and Pathological Findings by ANCA‐Subtype in ANCA‐Positive Idiopathic Interstitial Pneumonias
by: Tetsuro Sawata, et al.
Published: (2025-03-01)

Evaluation of ANCA testing by antigen-specific assays in small vessel vasculitis patients
by: Mai Mahmoud Fahmy Mansour, et al.
Published: (2025-04-01)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
by: John Chuan Nguyen Tran, et al.
Published: (2022-12-01)

Improvement of indirect immunofluorescence technique to detect antineutrophil cytoplasmic antibodies and its impact on test positivity rate
by: E.B. Zarur, et al.
Published: (2023-07-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
by: Charmaine van Eeden, et al.
Published: (2023-04-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

Neutrophils and Platelets as Key Players in the Pathogenesis of ANCA-Associated Vasculitis and Potential Sources of Disease Activity Biomarkers
by: Anna Drynda, et al.
Published: (2025-07-01)

Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus
by: Xin Chen, et al.
Published: (2023-05-01)

Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
by: Satomura Atsushi, et al.
Published: (2017-12-01)

Classifying ANCA-Associated Vasculitis and Correlating Outcomes Based on Anti-PR3/MPO Serology A Prospective Study from a Tertiary Care Center
by: Gayatri G. Ekbote, et al.
Published: (2022-07-01)

Rare Case of Renal Limited Dual Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Double Trouble!
by: Elenjickal Elias John, et al.
Published: (2022-05-01)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
by: Wei Lin, et al.
Published: (2021-03-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
by: Afroditi Maria Konstantouli, et al.
Published: (2022-09-01)

ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination—A Systematic Review
by: Kinga Łysak, et al.
Published: (2024-06-01)

Malignancies Presenting With ANCA Positivity: Two Case Reports and Diagnostic Considerations
by: Min Zhao, et al.
Published: (2025-08-01)

Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisons
by: Dhruti P. Chen, et al.
Published: (2026-06-01)

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study
by: Monica Gelzo, et al.
Published: (2021-08-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
by: Kazuhiro Kitamoto, et al.
Published: (2023-08-01)

Presentation and progression of MPO-ANCA interstitial lung disease
by: Lorenzo Salvati, et al.
Published: (2024-06-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

T-cell immunity in the experimental autoimmune vasculitis rat model
by: Ye Zeng, et al.
Published: (2025-12-01)

Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis
by: Gabriel Bossan, et al.
Published: (2025-09-01)

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population
by: Aya Kawasaki, et al.
Published: (2023-03-01)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
by: Marenao Tanaka, et al.
Published: (2017-11-01)

Low-dose rituximab for MPO-ANCA-associated hypertrophic pachymeningitis with delayed onset of renal involvement: a case report
by: Haohu Wu, et al.
Published: (2026-05-01)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN “REAL LIFE” – SERIES OF CLINICAL CASES IN A ROMANIAN REFERENCE CENTER
by: Mihaela-Lavinia Popescu, et al.
Published: (2017-12-01)

Diagnostic Impact of ANA Interference on p-ANCA Interpretation in Autoimmune Testing
by: Katelada Pengket, et al.
Published: (2026-06-01)

Microscopic polyangiitis: Modern concepts and treatment options
by: I. T. Murkamilov, et al.
Published: (2021-10-01)

Clinical significance of anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonia: a retrospective observational study
by: Xin Sun, et al.
Published: (2025-05-01)

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity
by: Eva Baier, et al.
Published: (2022-11-01)

Unilateral orbital mass as the initial presentation of pediatric antineutrophil cytoplasmic antibody associated vasculitis: eosinophilic granulomatosis with polyangiitis versus granulomatosis with polyangiitis
by: Paulien Bonny, et al.
Published: (2026-04-01)

Diagnostic Performance of ANCA IIF in Relation to PR3 and MPO Antibodies: Impact of Formalin Reactivity in a Large Real-World Cohort
by: Baris Can, et al.
Published: (2026-03-01)

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
by: Matthew David Morgan, et al.
Published: (2017-06-01)

Antineutrophil cytoplasmic antibodies in Chinese patients with tuberculosis
by: Gao Huan, et al.

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
by: L. Caroti, et al.
Published: (2019-05-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

PR3 vasculitis presenting with symptomatic splenic and renal infarction: a case report and literature review
by: M. J. Bottomley, et al.
Published: (2019-03-01)

Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases
by: Ourania D. Argyropoulou, et al.
Published: (2021-08-01)

Biomarker-guided IL-5 blockade achieves steroid-free MPO-ANCA seroconversion in EGPA
by: Osamu Matsuno, MD, PhD, et al.
Published: (2026-01-01)

Similarities and Differences Between Patients Diagnosed with ANCA-Associated Vasculitis Who Are Positive and Negative for ANCA: University Clinic Practice and Expertise
by: Giedre Dereseviciene, et al.
Published: (2025-07-01)